How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation

How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation

Moving from indication to transplantation is a critical process in myelofibrosis. Most of guidelines specifically focus on either myelofibrosis disease or transplant procedure, and, currently, no distinct indication for the management of MF candidates to transplant is available. Nevertheless, this p...

Full description

Bibliographic Details
Main Authors: Nicola Polverelli, Mirko Farina, Mariella D’Adda, Enrico Damiani, Luigi Grazioli, Alessandro Leoni, Michele Malagola, Simona Bernardi, Domenico Russo
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cells
Subjects:
myelofibrosis
allogeneic stem cell transplantation
bone marrow transplantation
ruxolitinib
splenectomy
JAK-inhibitors
Online Access:https://www.mdpi.com/2073-4409/11/3/553

Internet

https://www.mdpi.com/2073-4409/11/3/553

Similar Items